Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-01-25

FDA Approved: ALOGLIPTIN — Original Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

The FDA approves the original application for alogliptin for adults with type 2 diabetes mellitus to improve glycemic control.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alogliptin (alogliptin)

Snippet

ORIG AP for ALOGLIPTIN (ALOGLIPTIN)